StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca cardiovascular, Renal & Metabolism (CVRM) — Established RoW YoY actual (%) (%)

Form 6-K / 20-F Therapy Area Product Sales Table

Latest, Q2 2026
-16.0%
Period ended Jun 30, 2026
Change on a year earlier
-18.0 pts
2.0% in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCardiovascular, Renal & Metabolism (CVRM) — Established RoW YoY actual (%) (%)Year on yearSource
Q2 2026Jun 30, 2026-16.0%-18.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026-37.0%-46.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-15.0%-39.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-2.0%-11.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20252.0%+16.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20259.0%+11.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202424.0%+19.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20249.0%+3.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024-14.0%-33.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024-2.0%-6.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20235.0%+16.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20236.0%-5.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202319.0%+3.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20234.0%-24.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-11.0%-21.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202211.0%+12.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Cardiovascular, Renal & Metabolism (CVRM) — Established RoW YoY actual (%) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta_cvrm_erow_act_yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.